Zoekresultaten - 8 results

EU Oncology Decision Support Tool concept (CAN.HEAL Deliverable 10.1)

and interoperability of oncDSTs to support the management of oncological processes and drive further advancements in the field. The framework aims to support Molecular Tumor Board (MTB) operations ...

Reduced humoral immune response after BNT162b2 coronavirus disease 2019 messenger RNA vaccination in cancer patients under antineoplastic treatment.

PATIENTS AND METHODS: In this interventional prospective multicohort study, priming and booster doses of the BNT162 b2 COVID-19 vaccine were administered 21 days apart to solid tumor patients receiving ...

Lentiviral vector induces high-quality memory T cells via dendritic cells transduction.

lentiviral vector provided enhance therapeutic anti-tumor protection than Ad5. In conclusion, coupling lentiviral vector with β2-microglobulin promoter represents a promising approach to produce long-lasting, ...

Progressive Control of Streptococcus agalactiae-Induced Innate Inflammatory Response Is Associated with Time Course Expression of MicroRNA-223 by Neutrophils.

Tumor Necrosis Factor-alpha Abstract: Group B streptococcus (GBS) is a human-pathogenic bacterium inducing a strong inflammatory response that may be detrimental for host tissues if not finely regulated. ...

Development and validation of a protocol for optimizing the use of paraffin blocks in molecular epidemiological studies: The example from the HPV-AHEAD study.

A consensus histopathology evaluation form was developed by an international panel of pathologists and evaluated for four indicators in a pilot analysis in order to validate it: 1) presence/type of tumor ...

What are the immunologically active components of bacille Calmette-Guérin in therapy of superficial bladder cancer?

Vaccine CD56 Antigen Humans Interferon-gamma Interleukin-12 Interleukin-2 Interleukin-6 Leukocytes, Mononuclear Neoplasm Proteins Th1 Cells Tumor Cells, Cultured Urinary Bladder Neoplasms Abstract: The ...

What is the optimal regimen for BCG intravesical therapy? Are six weekly instillations necessary?

additional instillations because of tumor recurrence within 1 year of follow-up, the maximum immune response was observed already after 2 instillations. CONCLUSION: In most patients, the maximal peripheral ...

Perspectives on the integration of Immuno-Oncology Biomarkers and drugs in a Health Care setting.

Keywords: Antineoplastic Agents Biomarkers, Tumor Delivery of Health Care Humans Immunotherapy Medical Oncology Neoplasms Abstract: Immunotherapies, specifically checkpoint inhibitors, are becoming an ...

QR code

QR code for this page URL